Tozinameran/vemurafenibSkin toxicities and lack of efficacy

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2005卷 / 1期

关键词：

D O I：

10.1007/s40278-024-57868-9

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：775 / 775

相关论文

共 50 条

[21] AntineoplasticsVarious toxicities and lack of efficacy
Reactions Weekly, 2024, 2014 (1) : 74 - 74
[22] AntineoplasticsMultiple toxicities and lack of efficacy
Reactions Weekly, 2024, 2005 (1) : 94 - 94
[23] MobocertinibVarious toxicities and lack of efficacy
Reactions Weekly, 2024, 2007 (1) : 225 - 225
[24] AntineoplasticsVarious toxicities and lack of efficacy
Reactions Weekly, 2024, 2012 (1) : 44 - 44
[25] CotrimoxazoleVarious toxicities and lack of efficacy
Reactions Weekly, 2024, 2003 (1) : 283 - 283
[26] Prednisone/tozinameran/vinblastineRelapse of Evans syndrome and lack of efficacy: case report
Reactions Weekly, 2023, 1973 (1) : 248 - 248
[27] AsciminibVarious toxicities and lack of efficacy
Reactions Weekly, 2024, 1999 (1) : 58 - 58
[28] AntineoplasticsVarious toxicities and lack of efficacy
Reactions Weekly, 2024, 2010 (1) : 55 - 55
[29] DithranolVarious toxicities and lack of efficacy
Reactions Weekly, 2024, 2003 (1) : 341 - 341
[30] NivolumabVarious toxicities and lack of efficacy
Reactions Weekly, 2024, 2003 (1) : 654 - 654

← 1 2 3 4 5 →